Ng Tang Fui, Mark
Hoermann, Rudolf
Nolan, Brendan
Clarke, Michelle
Zajac, Jeffrey D.
Grossmann, Mathis
Article History
Received: 19 February 2018
Accepted: 4 June 2018
First Online: 14 June 2018
Competing Interests
: Mathis Grossmann has received research funding from Bayer Pharma, Novartis, Weight Watchers, Lilly and speaker’s honoraria from Besins Healthcare. Mark Ng Tang Fui has received research funding from Bayer Pharma. Rudolf Hoermann, Brendan Nolan, Michelle Clarke and Jeffrey D. Zajac declare that they have no competing interests.